title: Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats.
abstract: The endocannabinoid system has been implicated in several neurobiological processes, including neurodegeneration, neuroprotection and neuronal plasticity. The CB1 cannabinoid receptors are abundantly expressed in the basal ganglia, the circuitry that is mostly affected in Parkinson's Disease (PD). Some studies show variation of CB1 expression in basal ganglia in different animal models of PD, however the results are quite controversial, due to the differences in the procedures employed to induce the parkinsonism and the periods analyzed after the lesion. The present study evaluated the CB1 expression in four basal ganglia structures, namely striatum, external globus pallidus (EGP), internal globus pallidus (IGP) and substantia nigra pars reticulata (SNpr) of rats 1, 5, 10, 20, and 60 days after unilateral intrastriatal 6-hydroxydopamine injections, that causes retrograde dopaminergic degeneration. We also investigated tyrosine hydroxylase (TH), parvalbumin, calbindin and glutamic acid decarboxylase (GAD) expression to verify the status of dopaminergic and GABAergic systems. We observed a structure-specific modulation of CB1 expression at different periods after lesions. In general, there were no changes in the striatum, decreased CB1 in IGP and SNpr and increased CB1 in EGP, but this increase was not sustained over time. No changes in GAD and parvalbumin expression were observed in basal ganglia, whereas TH levels were decreased and the calbindin increased in striatum in short periods after lesion. We believe that the structure-specific variation of CB1 in basal ganglia in the 6-hydroxydopamine PD model could be related to a compensatory process involving the GABAergic transmission, which is impaired due to the lack of dopamine. Our data, therefore, suggest that the changes of CB1 and calbindin expression may represent a plasticity process in this PD model.
authors.affiliation: Laboratory of Neuronal Communication, Department of Physiology and Biophysics, University of São Paulo, São Paulo, Brazil.
authors.forename: Gabriela P
authors.initials: GP
authors.lastname: Chaves-Kirsten
authors.forename: Caio H Y
authors.initials: CH
authors.lastname: Mazucanti
authors.forename: Caroline C
authors.initials: CC
authors.lastname: Real
authors.forename: Bruna M
authors.initials: BM
authors.lastname: Souza
authors.forename: Luiz R G
authors.initials: LR
authors.lastname: Britto
authors.forename: Andréa S
authors.initials: AS
authors.lastname: Torrão
mesh_terms: D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism*; D064026:Calbindins / Q000378:metabolism; D005917:Globus Pallidus / Q000378:metabolism*; D015151:Immunoblotting; D007150:Immunohistochemistry; D008297:Male; D017072:Neostriatum / Q000378:metabolism*; D016627:Oxidopamine; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D043884:Receptor, Cannabinoid, CB1 / Q000378:metabolism*; D013378:Substantia Nigra / Q000378:metabolism*; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D064026:Calbindins; D043884:Receptor, Cannabinoid, CB1; D016627:Oxidopamine; D014446:Tyrosine 3-Monooxygenase